General Information of Drug Off-Target (DOT) (ID: OTXAG4PL)

DOT Name POC1 centriolar protein homolog A (POC1A)
Synonyms Pix2; Proteome of centriole protein 1A; WD repeat-containing protein 51A
Gene Name POC1A
Related Disease
Fanconi anemia complementation group Q ( )
Acute myocardial infarction ( )
Chromosomal disorder ( )
Ciliopathy ( )
Coronary atherosclerosis ( )
Coronary heart disease ( )
Fatty liver disease ( )
Male infertility ( )
Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ( )
Type-1/2 diabetes ( )
Myocardial ischemia ( )
Obesity ( )
Breast cancer ( )
Breast carcinoma ( )
UniProt ID
POC1A_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00400
Sequence
MAAPCAEDPSLERHFKGHRDAVTCVDFSINTKQLASGSMDSCLMVWHMKPQSRAYRFTGH
KDAVTCVNFSPSGHLLASGSRDKTVRIWVPNVKGESTVFRAHTATVRSVHFCSDGQSFVT
ASDDKTVKVWATHRQKFLFSLSQHINWVRCAKFSPDGRLIVSASDDKTVKLWDKSSRECV
HSYCEHGGFVTYVDFHPSGTCIAAAGMDNTVKVWDVRTHRLLQHYQLHSAAVNGLSFHPS
GNYLITASSDSTLKILDLMEGRLLYTLHGHQGPATTVAFSRTGEYFASGGSDEQVMVWKS
NFDIVDHGEVTKVPRPPATLASSMGNLPEVDFPVPPGRGRSVESVQSQPQEPVSVPQTLT
STLEHIVGQLDVLTQTVSILEQRLTLTEDKLKQCLENQQLIMQRATP
Function
Plays an important role in centriole assembly and/or stability and ciliogenesis. Involved in early steps of centriole duplication, as well as in the later steps of centriole length control. Acts in concert with POC1B to ensure centriole integrity and proper mitotic spindle formation.

Molecular Interaction Atlas (MIA) of This DOT

14 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Fanconi anemia complementation group Q DISHYVNK Definitive Autosomal recessive [1]
Acute myocardial infarction DISE3HTG Strong Genetic Variation [2]
Chromosomal disorder DISM5BB5 Strong Genetic Variation [3]
Ciliopathy DIS10G4I Strong Genetic Variation [4]
Coronary atherosclerosis DISKNDYU Strong Genetic Variation [2]
Coronary heart disease DIS5OIP1 Strong Genetic Variation [2]
Fatty liver disease DIS485QZ Strong Genetic Variation [1]
Male infertility DISY3YZZ Strong Biomarker [5]
Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome DISN8GYD Strong Autosomal recessive [4]
Type-1/2 diabetes DISIUHAP Strong Biomarker [6]
Myocardial ischemia DISFTVXF moderate Genetic Variation [7]
Obesity DIS47Y1K moderate Biomarker [8]
Breast cancer DIS7DPX1 Limited Biomarker [9]
Breast carcinoma DIS2UE88 Limited Biomarker [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 14 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
14 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of POC1 centriolar protein homolog A (POC1A). [10]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of POC1 centriolar protein homolog A (POC1A). [11]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of POC1 centriolar protein homolog A (POC1A). [12]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of POC1 centriolar protein homolog A (POC1A). [13]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of POC1 centriolar protein homolog A (POC1A). [14]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide affects the expression of POC1 centriolar protein homolog A (POC1A). [15]
Calcitriol DM8ZVJ7 Approved Calcitriol decreases the expression of POC1 centriolar protein homolog A (POC1A). [16]
Testosterone DM7HUNW Approved Testosterone decreases the expression of POC1 centriolar protein homolog A (POC1A). [16]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of POC1 centriolar protein homolog A (POC1A). [17]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide decreases the expression of POC1 centriolar protein homolog A (POC1A). [18]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 decreases the expression of POC1 centriolar protein homolog A (POC1A). [19]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of POC1 centriolar protein homolog A (POC1A). [20]
Coumestrol DM40TBU Investigative Coumestrol increases the expression of POC1 centriolar protein homolog A (POC1A). [21]
QUERCITRIN DM1DH96 Investigative QUERCITRIN decreases the expression of POC1 centriolar protein homolog A (POC1A). [22]
------------------------------------------------------------------------------------
⏷ Show the Full List of 14 Drug(s)

References

1 Truncation of POC1A associated with short stature and extreme insulin resistance. J Mol Endocrinol. 2015 Oct;55(2):147-58. doi: 10.1530/JME-15-0090.
2 Mechanisms of Myocardial Infarction inPatients With Nonobstructive Coronary Artery Disease: Results From the Optical Coherence Tomography Study.JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 1):2210-2221. doi: 10.1016/j.jcmg.2018.08.022. Epub 2018 Oct 17.
3 The effect of associated structural malformations in the prediction of chromosomal abnormality risk of fetuses with echogenic bowel.J Matern Fetal Neonatal Med. 2016;29(1):41-5. doi: 10.3109/14767058.2014.986091. Epub 2014 Dec 5.
4 POC1A truncation mutation causes a ciliopathy in humans characterized by primordial dwarfism. Am J Hum Genet. 2012 Aug 10;91(2):330-6. doi: 10.1016/j.ajhg.2012.05.025. Epub 2012 Jul 26.
5 LINE-1 Mediated Insertion into Poc1a (Protein of Centriole 1 A) Causes Growth Insufficiency and Male Infertility in Mice.PLoS Genet. 2015 Oct 23;11(10):e1005569. doi: 10.1371/journal.pgen.1005569. eCollection 2015 Oct.
6 Effect of glutamate and aspartate on ischemic heart disease, blood pressure, and diabetes: a Mendelian randomization study.Am J Clin Nutr. 2019 Apr 1;109(4):1197-1206. doi: 10.1093/ajcn/nqy362.
7 Effects of copper and zinc on ischemic heart disease and myocardial infarction: a Mendelian randomization study.Am J Clin Nutr. 2018 Aug 1;108(2):237-242. doi: 10.1093/ajcn/nqy129.
8 Bifidobacteria and its rice fermented products on diet induced obese mice: analysis of physical status, serum profile and gene expressions.Benef Microbes. 2018 Apr 25;9(3):441-452. doi: 10.3920/BM2017.0056. Epub 2018 Feb 7.
9 An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project.BMC Cancer. 2018 Sep 27;18(1):932. doi: 10.1186/s12885-018-4843-2.
10 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
11 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
12 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
13 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
14 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
15 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
16 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
17 Transcriptional signature of human macrophages exposed to the environmental contaminant benzo(a)pyrene. Toxicol Sci. 2010 Apr;114(2):247-59.
18 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
19 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
20 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
21 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
22 Molecular mechanisms of quercitrin-induced apoptosis in non-small cell lung cancer. Arch Med Res. 2014 Aug;45(6):445-54.